Clinical Trials in Philadelphia

Showing 11241-11260 of 17,926 trials

A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer

NCT02159703

To determine 2-year local (primary tumor site) control and toxicity rates in patients receiving adjuvant RT post-TORS, omitting the primary tumor bed, in patients with completely resected, HPV-positive SCCA of the oropharynx. To determine acute and long-term toxicity rates in patients receiving adjuvant RT post-TORS, omitting the primary tumor bed, in patients with completely resected, HPV-positive SCCA of the oropharynx.

Oropharyngeal Cancer

Abramson Cancer Center at Penn Medicine60 participantsStarted Feb 2014

Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years

NCT01373177

The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.

Infant Development

Children's Hospital of Philadelphia119 participantsStarted Jan 2011

Philadelphia, Pennsylvania, United States

A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer

Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years

Find Trials by Condition in Philadelphia

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS

Safety of Intravenous Neridronic Acid in CRPS

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors

Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Interactive Cancer Communication System (ICCS) Directed Physical Activity Enhancement for Colon Cancer Survivors

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease